Study of chemotherapy resistance in high-grade ovarian cancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This study looks at why some high-grade ovarian cancers stop responding to standard chemotherapy. It aims to find ways to overcome that resistance, which may help improve treatment outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be at least 25 years old
- Have a confirmed diagnosis of high-grade serous ovarian cancer
- Have not had surgery to remove the cancer yet
- Be willing to provide a sample of tumor tissue for research
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses artificial intelligence to help doctors choose the best treatment for high-grade serous ovarian cancer. It looks at your tumor samples and medical history to personalize your care.
This study tests a personalized cancer therapy designed just for you and your tumor. It is for people with newly diagnosed advanced ovarian cancer who can wait a short time before starting treatment and plan to have surgery after 2 cycles of chemotherapy.
This study looks at how medical images relate to genetic patterns in high-grade serous ovarian cancer. It may help find better ways to diagnose and treat this specific type of ovarian cancer.
This study is looking at how ovarian cancer affects the mesentery (the tissue that holds your intestines in place) in women with advanced ovarian cancer. It helps doctors understand the disease better and may lead to improved treatments.
This trial uses a special imaging technique to study high-grade serous ovarian cancer. It aims to better understand the tumor to improve treatment. If you have advanced ovarian cancer and are scheduled for surgery, you may be eligible.
This study looks at how to best detect the HER2 protein in high-grade serous ovarian cancer. The goal is to improve treatment choices for people with this type of cancer.
Hear when a new High-grade Serous Ovarian Carcinoma (HGSOC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.